结论：黄芪精口服液对老年慢性支气管哮喘有较好的防治作用，有一定的临床实用价值。
Conclusion Oral liquid preparation of astragalus membranaceous was therapeutically useful for chronic bronchial asthma in aged patients with correction of the serum SOD levels.
支气管哮喘是一种由多种细胞和细胞组分参与的气道慢性炎症性疾病。
Bronchial asthma is a chronic inflammatory disorder of the airway in which many cells and cellular elements play a role.
支气管哮喘是一种慢性气道炎症性疾病。
Allergic bronchial asthma is characterized by chronic airway inflammation.
支气管哮喘是一种发病机制复杂的气道慢性炎症，临床有众多作用机制不同的药物可选用，但目前药物治疗尚无法彻底予以根治。
Bronchial asthma is a chronic respiratory with different mechanisms are used in clinic but asthma airway inflammation with complex pathogenesis. Many drugs can not be cured completely by drug therapy.
支气管哮喘是一种慢性气道炎症性疾病。
Bronchial asthma is a chronicity airway inflammation disease.
易与支气管哮喘、慢性支气管炎等混淆。
It is easy to confuse with bronchial asthma and chronic bronchitis.
内科方面：慢性支气管炎、支气管哮喘、慢性胃炎、消化性溃疡、糖尿病、慢性盆腔炎、痛经等。
In internal medicine: chronic bronchitis, bronchial asthma, chronic gastritis, peptic ulcer, diabetes mellitus, chronic pelvic inflammatory disease and algomenorrhea, etc.
方法采用放射免疫分析方法，测定36例支气管哮喘发作期与缓解期患者，20 例慢性支气管炎急性发作期患者血浆心钠素（ANF） 水平。
Methods The plasma ANF in 36 patients with asthma was measured during acute attack and remission by RIA kit and compared with that in 20 patients with acute attack of chronic bronchitis.
慢性支气管炎、支气管哮喘，按疗程治疗后大都可以治愈，部分患者需延长治疗时间。
After the course of the treatment, most of the diseases of chronic bronchitis and bronchial asthma can be cured while some patients have to extend their treatment time.
支气管哮喘是一种常见的慢性呼吸道疾病，其免疫发病机制尚不十分清楚。
Asthma is a frequent chronic respiratory disease, whose immunological pathogenesis is not clear completely.
目的支气管哮喘(简称哮喘)是一种以气道慢性非特异性炎症和气道高反应为特征的常见肺部疾病。
Objective: Asthma is a pulmonary disease characterized by chronic inflammation of the airways and bronchial hyperresponsiveness.
支气管哮喘是儿童常见的慢性病之一，近年来其患病率和死亡率在世界各国均出现明显上升趋势。
Bronchial asthma is a common chronic disease in children. In recent years, its prevalence rate and mortality have evidently increased in the world.
结论：异丁司特缓释胶囊是一种安全有效的治疗支气管哮喘和慢性喘息性支气管炎的药物。
Conclusion: Ibudilast su stained-release capsule is an effective agent for treatment of asthma or chronic asthmatic bronchitis.
支气管哮喘（简称哮喘）是遗传因素和环境因素共同参与，以慢性呼吸道炎症、呼吸道高反应性及呼吸道重塑为特征的综合征。
Bronchial asthma(the asthma) commonly involves both genetic factors and environmental factors, characterized by chronic airway inflammation, airway hyper-responsiveness and airway remodeling.
支气管哮喘（简称哮喘）是遗传因素和环境因素共同参与，以慢性呼吸道炎症、呼吸道高反应性及呼吸道重塑为特征的综合征。
Bronchial asthma(the asthma) commonly involves both genetic factors and environmental factors, characterized by chronic airway inflammation, airway hyper-responsiveness and airway remodeling.
应用推荐